Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 839 results for "myers"

Fort Myers Plastic Surgeon Introduces a New and Improved Body ...

A Board certified plastic surgeon in Fort Myers, FL, Dr. Ralph Garramone introduced CoolSculpting Plus, an advanced approach to body contouring. About the basic CoolSculpting procedure: The CoolSculpting procedure is the only FDA-cleared, ... PRWeb, 11 hours ago
[x]  

5,515 images for myers

DCMilitary Pentagram, 1 hour ago
KMOV.com, 1 day ago
Lismore Northern Star, 1 day ago
Milwaukee Journal Sentinel, 2 days ago
DCMilitary Pentagram, 1 hour ago
DCMilitary Pentagram, 1 hour ago
DCMilitary Pentagram, 1 hour ago
DCMilitary Pentagram, 1 hour ago
DCMilitary Pentagram, 1 hour ago
DCMilitary Pentagram, 1 hour ago

Relatively High Future Earnings Growth Detected in Shares of Myers Industries in the Metal & Glass Containers Industry (MYE, GEF, OI, ATR, CCK)

(Comtex SmarTrend(R)) Below are the three companies in the Metal & Glass Containers industry with the highest future earnings growth. The growth of earnings per share (next fiscal year estimated vs. current fiscal year estimated) is important to ...
 Individual.com8 hours ago Myers Industries Inc. (MYE) is Trading Higher on Unusual Volume for July 01  Equities.com12 hours ago

Watch for Bristol-Myers Squibb to Potentially Pullback After Gaining 1.70% Yesterday

Bristol-Myers Squibb (NYSE:BMY) traded in a range yesterday that spanned from a low of $66.36 to a high of $67.71. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $67.68 on volume of 7.5 million shares. ...
 Individual.com21 hours ago

Bristol-Myers Squibb (BMY) Breaks Through Resistance at $66.85

Shares of Bristol-Myers Squibb (NYSE:BMY) opened today above their pivot of $66.40 and have already reached the first level of resistance at $66.85. Analysts will be watching for a cross of the next upside pivot targets of $67.17
 Individual.com1 day ago
ACQ Magazine

How Picking Value Stocks Is Like Looking For A 6-Foot Tall Second Grader

When Chuck Myers' scans the stock market these days, he doesn't see an awful lot to get terribly excited about. That isn't exactly shocking, considering Myers, portfolio manager of the $6 billion Fidelity Small Cap Discovery Fund, is a value ...
 Austin American Statesman1 day ago How A Great Value Stock Is Like A 6-Foot Tall Second Grader  ACQ Magazine1 day ago
Business Standard

Cipla, BMS settles patent dispute

The patent dispute between US-based pharma major Bristol-Myers Squibb (BMS) and Indian pharma major Cipla Ltd over entecavir, a pharmaceutical combination for treating Hepatitis B has been settled amicably out of the court. Based on the endorsement made in ...
 Business Standard2 weeks ago
TheStreet.com

NeoGenomics Schedules Its Q2 2015 Earnings Release For July 23, 2015

Reddit Email Print Reprint FT. MYERS, Fla., June 30, 2015 /PRNewswire/ --NeoGenomics, Inc. (NASDAQ: NEO ) announced today that it plans to release its second quarter 2015 financial results on Thursday July 23, 2015 . The Company has ...
 TheStreet.com1 day ago National IPOs Rise 59 Percent In Second Quarter  Michigan Technology News5 hours ago NeoGenomics, Inc. (NGNM.OB) Schedules Its Q2 2015 Earnings Release For July 23, 2015 7/1/2015  ClinicSpace1 day ago NeoGenomics, Inc. Schedules Its Q2 2015 Earnings Release For July 23, 2015  BioSpace1 day ago
[x]  

FGCU School of Resort & Hospitality Management Collaborates with United States Personal Chef Association to Provide Training Opportunities for Chefs and Entrepreneurs

FORT MYERS, Fla., Jul. 1, 2015 /PRNewswire-iReach/ -- FORT MYERS, Fla. The School of Resort and Hospitality Management at Florida Gulf Coast University (FGCU) will collaborate with the United
 Yahoo! Canada1 day ago
Reuters

Bristol-Myers to stop new antiviral drug research

Bristol-Myers Squibb said on Thursday that it would stop efforts to find new antiviral drugs and cut 100 related jobs. The company said it will also discontinue its Hepatitis B and HIV early programs. Bristol-Myers said already marketed products and its ...
 Reuters1 week ago Bristol, AbbVie drug extends multiple myeloma remission: study  Reuters1 month ago U.S. top court rejects hepatitis B drug patent case  Reuters1 month ago Bristol-Myers says hepatitis C drug combination succeeds in study  Reuters2 months ago
Med India

Bristol wins EU green light for immune system cancer drug

LONDON (Reuters) - European regulators have recommended approval of Bristol-Myers Squibb's Opdivo, paving the way for it to become the first of a closely watched group of immune system-boosting cancer medicines to go on sale in Europe. The drug, also known as ...
 Reuters2 months ago Merck follows Bristol with EU green light for immune cancer drug  Reuters1 month ago Merck & Co'smdrug cancer drug Keytruda gets a nod  Economic Times1 month ago Merck & Co's immune system-boosting cancer drug Keytruda gets a nod from European regulators  Economic Times1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - myers
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less